健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XLV 健康照护类股ETF-SPDR

休市中 06-18 16:00:00 EDT

149.40

-1.31

-0.87%

盘后149.66

+0.26+0.17%

19:58 EDT

最高151.27	最低148.79	成交量1,088万
今开151.27	昨收150.71	日振幅1.65%
总市值382.19亿	流通市值382.19亿	总股本2.56亿
成交额16.27亿	换手率4.25%	流通股本2.56亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"健康照护类股ETF-SPDR","latestPrice":149.4,"timestamp":1781812800000,"preClose":150.71,"halted":0,"volume":10879276,"hourTrading":{"tag":"盘后","latestPrice":149.66,"preClose":149.4,"latestTime":"19:58 EDT","volume":146591,"amount":21900671.3956,"timestamp":1781827099264,"change":0.26,"changeRate":0.00174,"amplitude":0.004284},"delay":0,"changeRate":-0.00869219029925023,"floatShares":255815324,"shares":255815324,"eps":-14.217021,"marketStatus":"休市中","change":-1.31,"latestTime":"06-18 16:00:00 EDT","open":151.27,"high":151.27,"low":148.79,"amount":1627499871.44984,"amplitude":0.016455,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":150.71,"sharesOutstanding":267365324,"nav":149.435878,"aum":37533110724.15,"dividendRate":0.016367,"bidAskSpread":0.000086,"preHourTrading":{"tag":"盘前","latestPrice":151.25,"preClose":150.68,"latestTime":"09:29 EDT","volume":8406,"amount":1268742.12552,"timestamp":1781789358548,"change":0.57,"changeRate":0.003783,"amplitude":0.010607},"postHourTrading":{"tag":"盘后","latestPrice":149.66,"preClose":149.4,"latestTime":"19:58 EDT","volume":146591,"amount":21900671.3956,"timestamp":1781827099264,"change":0.26,"changeRate":0.00174,"amplitude":0.004284},"volumeRatio":1.1145335898066735,"optionData":{"bulkOrders":[{"symbol":"XLV","call":false,"expireDate":1799989200000,"strike":"150.0","timestamp":1781790849362,"price":6.64,"volume":3000,"amount":1992000,"type":"-"}]},"impliedVol":0.1404,"impliedVolPercentile":0.1155},"requestUrl":"/m/hq/s/XLV/tweets","defaultTab":"tweets","newsList":[{"id":"1188412868","title":"医疗保健板块市场动态汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=1188412868","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188412868?lang=zh_cn&edition=full","pubTime":"2026-06-19 16:22","pubTimestamp":1781857371,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场动态。有机构因此将其目标价从0.75林吉特下调至0.68林吉特。股价应声下跌2.1%，报0.71林吉特。股价持平于0.72林吉特。近期公布的经济数据显示内需依然疲软，因此消费必需品和医疗保健等低估值板块的触底回升可能需要更长时间。百济神州的收入预计将在2026年达到65亿美元，主要得益于其旗舰抗癌药百悦泽。随着百悦泽持续扩大规模并占据更多市场份额，预计长期利润率将扩大400个基点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BVA.SI","BK6511","LABU","XLV","BK4588","XBI","BK6103","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128887518","title":"医疗保健板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1128887518","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128887518?lang=zh_cn&edition=full","pubTime":"2026-06-18 04:52","pubTimestamp":1781729571,"startTime":"0","endTime":"0","summary":"最新一期医疗保健板块市场动态速递。美国制药巨头默克公司预计将于明年公布其炎症性肠病候选药物tulisokibart的后期试验数据。此前于格林尼治时间1435发布的“罗氏或将成为新型自身免疫药物领域赢家——市场动态”一文中，曾误将tulisokibart称为治疗肠易激综合征的候选药物，特此更正。他们补充道，由于市场竞争以及对其NES诊断设备将逐步推出的预期，德意志银行对DiaSorin的收入增长势头和盈利前景持比市场更为谨慎的态度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","LABU","XLV","SOCL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148486514","title":"医疗保健板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1148486514","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148486514?lang=zh_cn&edition=full","pubTime":"2026-06-18 00:22","pubTimestamp":1781713368,"startTime":"0","endTime":"0","summary":"美国制药巨头默克公司预计将于明年公布其治疗炎症性肠病的候选药物tulisokibart的后期试验数据。此前一则市场快讯曾错误地将该药物适应症描述为肠易激综合征。EssilorLuxottica的智能眼镜定价远低于新进入市场的竞争对手。Snap过高的定价令市场担忧，并对其股价构成压力。4E公司表示，其正在开发针对慢性疼痛的治疗方法，致力于研发能在提供有效镇痛的同时避免许多现有疗法对中枢神经系统影响的化合物。双方未披露交易条款。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","BK4588","XBI","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194492061","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1194492061","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194492061?lang=zh_cn&edition=full","pubTime":"2026-06-17 00:23","pubTimestamp":1781626991,"startTime":"0","endTime":"0","summary":"市场最新谈话聚焦医疗健康板块。据伯恩斯坦分析，所谓的抗TL1A药物类别似乎被投资者低估了，但到2040年，这类药物的市场价值可能达到660亿美元。不过，他们补充道，凭借afimkibart，罗氏预计将成为市场领导者。欧洲斯托克600医疗健康指数下跌0.45%。Zealand股价下跌4.8%，罗氏股价下跌0.5%。马来亚银行将泰国医疗保健板块的评级从中性上调至积极，并将曼谷医院和朱拉隆功医院列为其首选。瑞银还提到了公平工作委员会关于提高医疗专业人员工资的裁决。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","LABU","BK4534","LU1863844665.USD","XBI","UBS","LU3187612489.SGD","BK4585","LU1863844749.USD","IE0034235071.USD","BK4118","LU1829250122.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167341696","title":"医疗健康板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1167341696","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167341696?lang=zh_cn&edition=full","pubTime":"2026-06-12 04:53","pubTimestamp":1781211222,"startTime":"0","endTime":"0","summary":"在近期举行的美国糖尿病协会会议上，诺和诺德确认，口服Wegovy自推出以来已开具300万份处方。“整整82%的处方医生是体重管理领域的新手，我们认为这表明口服疗法正在帮助扩大市场。”会议还重点介绍了几项新研究，这些研究间接加强了对GLP-1疗法在体重管理中应用的支持，这可能有助于在保险公司和监管机构此前限制较多的市场（如瑞典）提高治疗可及性。股价下跌1%，至280.20丹麦克朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4581","XLV","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133908394","title":"医疗保健板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1133908394","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133908394?lang=zh_cn&edition=full","pubTime":"2026-06-12 00:23","pubTimestamp":1781194997,"startTime":"0","endTime":"0","summary":"最新一期医疗保健板块市场动态聚焦于行业内的关键讨论。SB1 Markets认为，该公司目前在口服肥胖治疗领域拥有明显优势，而礼来则在注射疗法领域占据相应领先地位。在近期举行的美国糖尿病协会会议上，诺和诺德确认，自上市以来，口服Wegovy已开出300万张处方。SB1 Markets指出：“高达82%的处方医生是体重管理领域的新手，在我们看来，这表明口服疗法正在帮助扩大市场。”诺和诺德股价下跌1%，至280.20丹麦克朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XBI","XLV","BK4581","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191053663","title":"医疗保健板块热点速递：市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1191053663","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191053663?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:23","pubTimestamp":1781166219,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗保健板块的市场动态速递。阿斯利康股价开盘基本持平。该公司股价下跌2.1%，至366.00印尼盾。欧洲斯托克600医疗保健指数上涨0.5%。瑞银分析师在一份研究报告中表示，葛兰素史克拟议收购Nuvalent的交易对这家英国制药商而言是绝佳匹配，并为其未来推出肺癌药物ris-rez奠定了基础。瑞银表示，这两款Nuvalent药物通过改善现有疗法的疗效和耐受性，合计有潜力实现37.5亿美元的峰值销售额。葛兰素史克股价大体持平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LABU","BK4588","BK4585","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139258159","title":"医疗健康板块综述：市场热议聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1139258159","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139258159?lang=zh_cn&edition=full","pubTime":"2026-06-11 04:55","pubTimestamp":1781124902,"startTime":"0","endTime":"0","summary":"欧洲大型制药企业在今年下半年将迎来繁忙日程，数项关键事件有望助其构建积极前景并赢得投资者青睐。据美国银行分析师指出，诺华和阿斯利康在临床试验结果公布方面日程最为密集。此外，分析师补充道，葛兰素史克和赛诺菲新近任命的首席执行官预计将在第二季度财报发布之际，就其战略规划提供最新进展。对于诺和诺德，美国银行表示，市场关注焦点仍将集中在其肥胖与糖尿病产品的处方趋势上。斯托克欧洲600医疗保健指数目前上涨0.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LABU","XBI","BK4585","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174033257","title":"医疗健康板块综述：市场动态聚焦制药巨头与手套商","url":"https://stock-news.laohu8.com/highlight/detail?id=1174033257","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174033257?lang=zh_cn&edition=full","pubTime":"2026-06-11 00:23","pubTimestamp":1781108609,"startTime":"0","endTime":"0","summary":"欧洲大型制药公司下半年日程紧凑，一系列关键事件有望助其构建积极前景并赢得投资者青睐。他们补充道，葛兰素史克和赛诺菲新近任命的首席执行官预计将在发布第二季度财报时，同步更新其战略规划。对于诺和诺德，分析师认为其焦点仍将集中在肥胖与糖尿病产品的处方趋势上。罗氏的下半年则相对平静，但其新型乳腺癌药物giredestrant的上市将成为关键。欧洲斯托克600医疗健康指数当前上涨0.5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","BK4588","BK4585","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156980149","title":"医疗健康板块热点速递：市场动态一览","url":"https://stock-news.laohu8.com/highlight/detail?id=1156980149","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156980149?lang=zh_cn&edition=full","pubTime":"2026-06-10 04:53","pubTimestamp":1781038402,"startTime":"0","endTime":"0","summary":"最新一期医疗健康板块市场动态速递。此次上调规模表明，市场对Apotex及其股东出售股票的需求强劲，足以支持其超越最初的计划。葛兰素史克股价下跌1.3%。瑞银分析师维持对该股的买入评级，但在给客户的报告中警告称，市场普遍预测CSL血浆制品业务利润率将扩大90个基点，这一预期过高。他们预计，每位捐赠者采集量增长10%将带来改善，并称这将有助于抵消价格和竞争压力。股价上涨0.6%至98.49澳元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","LABU","BK4139","BK4539","XLV","NUVL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152725195","title":"医疗保健板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1152725195","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152725195?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:23","pubTimestamp":1780993391,"startTime":"0","endTime":"0","summary":"科技股反弹抵消了医疗保健和软件板块的跌幅，泛欧斯托克600指数表现持平。伦敦富时100指数下跌0.3%，因医疗保健股走低，其中葛兰素史克在同意收购生物制药公司Nuvalent后股价下跌2.5%。软件公司励讯集团和赛捷集团均下跌约2%。银行和奢侈品集团的温和上涨助力法国CAC 40指数上扬0.3%。德国DAX指数微升0.1%，得益于半导体公司英飞凌科技股价上涨2.7%。意大利银行股延续涨势，推动米兰富时MIB指数上涨0.7%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","BK4588","BK4585","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149997054","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1149997054","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149997054?lang=zh_cn&edition=full","pubTime":"2026-06-06 00:26","pubTimestamp":1780676796,"startTime":"0","endTime":"0","summary":"最新一期医疗健康板块市场动态发布。美东时间凌晨2点06分 - 伯恩斯坦分析师在一份研究报告中指出，阿斯利康在其核心肿瘤业务之外发布的管线药物数据前景乐观，但市场似乎低估了其价值。Bell Potter表示，这一差距反映了过去几个月，在市场等待EBR启动融资期间，其股价的急剧下跌。EBR Systems股价下跌11%，报0.39澳元。（本文已进行更正，以反映EBR Systems计划以每股0.38澳元筹集1.08亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","BK4581","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641161560","title":"欧洲股市反弹 医疗保健板块领涨 渣打和汇丰等英国银行股下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2641161560","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641161560?lang=zh_cn&edition=full","pubTime":"2026-06-05 01:42","pubTimestamp":1780594920,"startTime":"0","endTime":"0","summary":"欧洲股市周四反弹，医疗保健股上涨，Abivax SA和Zealand Pharma A/S涨幅居前。　　斯托克欧洲600指数收盘上涨0.5%，摆脱早盘跌势。医疗保健、金融服务和零售板块领涨，矿业股和电信股表现最差。　　Abivax大涨18%，此前该股因一项关键临床试验中的癌症病例而暴跌。　　欧洲股市今年以来上涨逾5%，但仍落后于美国和亚洲市场的涨势，后两者对AI主题的敞口更大。这导致瑞银集团的一篮子AI赢家股票下跌1.6%，不过该篮子今年以来仍上涨逾40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-05/doc-iniahnxk9041101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0149534421.HKD","IEFA","LU1267930227.SGD","FEZ","BK4534","LU0496365809.HKD","BK1619","VEA","XBI","LU0310800965.SGD","BK4207","STAN.UK","BK1601","FLEE","SG9999001689.USD","LU0976567544.SGD","BK4550","HSBC","LU0211326755.USD","03143","BK4588","02888","LU0052756011.USD","VGK","EURL","LU0211326839.USD","EPV","XLV","LU0211977185.USD","SG9999000327.SGD","VHT","LU0607220059.USD","BK4581","HSBH","IEUR","BK4504","LABU","LU0128525689.USD","LU2236285917.USD","SPEU","IEV","BK1572","BK1231","BK4585","BK4521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120703317","title":"医疗保健板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1120703317","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120703317?lang=zh_cn&edition=full","pubTime":"2026-06-04 00:22","pubTimestamp":1780503772,"startTime":"0","endTime":"0","summary":"0548 ET - AJ Bell的Russ Mould指出，诺和诺德在阿联酋推出其口服减肥药Wegovy是一个重要的里程碑，这标志着该公司首次在美国以外地区推出其肥胖治疗药物的口服版本。Mould称，这一点在美国市场已得到印证，口服剂型于今年初推出后，需求一直很健康。诺和诺德的主要竞争对手礼来公司已于四月宣布在阿联酋推出其自身的口服减肥药。诺和诺德股价上涨0.1%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","BK4585","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196937471","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1196937471","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196937471?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:26","pubTimestamp":1780475203,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康板块的市场对话。他表示，明年公司员工将可以免费使用GLP-1药物，因为他相信这将有助于降低公司的整体医疗成本。分析师表示，负责监督和有权管辖跨地区诉讼的法官小组已将集体诉讼移交至北加州联邦法院，由法官Vince Chhabria审理。该法官在最近的听证会上对该和解方案持负面看法，并在2020年驳回了拜耳解决Roundup诉讼的尝试。拜耳股价下跌5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4581","XLV","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111791195","title":"医疗健康板块市场动态汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=1111791195","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111791195?lang=zh_cn&edition=full","pubTime":"2026-06-03 04:53","pubTimestamp":1780433606,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康领域的市场对话。他指出，服用这些减肥药的人正在购买更多浆果以确保获得足够的营养。他本人正推动 Driscoll's 为员工报销更多GLP-1类药物费用，并称明年将为员工免费提供这类药物，因为他认为这将降低公司的整体医疗成本。拜耳股价下跌5%。Paragon Care的盈利预警使其失去了一位看涨者。Bell Potter指出，Paragon Care此前9700万至1.07亿澳元的指引未包含Haju Medical。Bell Potter将Paragon Care的评级从买入下调至持有，并将其目标价大幅下调逾40%，至每股0.17澳元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XLV","BK4588","LABU","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198010928","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1198010928","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198010928?lang=zh_cn&edition=full","pubTime":"2026-06-03 00:24","pubTimestamp":1780417443,"startTime":"0","endTime":"0","summary":"最新一期医疗健康板块市场动态发布。分析师们就行业关键事件展开热议。该股股价下跌31%。Paragon Care的盈利预警使其失去了一位看涨者。Paragon Care目前预计2026财年收入为37亿澳元，息税折旧摊销前利润在9500万至1亿澳元之间。Bell Potter指出，Paragon Care此前给出的9700万至1.07亿澳元的指引未包含Haju Medical。他将2026财年和2027财年的每股收益预测分别下调了10%和18%。Bell Potter将Paragon Care的评级从买入下调至持有，并将其目标价大幅下调逾40%，至每股0.17澳元。Paragon Care周一收于每股0.16澳元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","XLV","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182826648","title":"医疗健康板块综述：市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1182826648","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182826648?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:29","pubTimestamp":1780302564,"startTime":"0","endTime":"0","summary":"医疗健康板块最新市场动态一览。然而，公司的核心业务依然稳健，目前其价值被低估且受到忽视。该公司股价下跌0.4%，报174.45欧元。这家印度公司正将其在国内资本效率高的店中店模式及公私合营模式复制到海外市场。上午5点42分——在加拿大皇家银行资本市场看来，Pro Medicus新合同的期限被视为好消息。加拿大皇家银行给予该股与大市同步评级，目标价为195.00澳元。该股上涨8.1%，报142.95澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","XLV","LABU","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639607386","title":"国家医保局发布2026年国家医保目录调整工作方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2639607386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639607386?lang=zh_cn&edition=full","pubTime":"2026-05-31 10:19","pubTimestamp":1780193940,"startTime":"0","endTime":"0","summary":"自2027年开始，截止日期将确定为方案发布之日","market":"fut","thumbnail":"https://img3.gelonghui.com/f3af3-4ae020e2-682d-46bb-8d75-0673a1077883.jpg?guru_height=3384&guru_width=4608&guru_size=1145570","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/f3af3-4ae020e2-682d-46bb-8d75-0673a1077883.jpg?guru_height=3384&guru_width=4608&guru_size=1145570"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4990180","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["XBI","BK4585","XLV","LABU","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639960204","title":"国家医保局发布2026年国家医保目录调整工作方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2639960204","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639960204?lang=zh_cn&edition=full","pubTime":"2026-05-31 09:20","pubTimestamp":1780190400,"startTime":"0","endTime":"0","summary":"据央视新闻消息，国家医保局今天发布《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整申报指南》《谈判药品续约规则》以及《非独家药品竞价规则》。同时，为帮助社会各界加深对政策的理解，组织编制了《国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整常用问答》。","market":"us","thumbnail":"https://media.bjnews.com.cn/cover/2024/12/23/5535172268222656082.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2024/12/23/5535172268222656082.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1780190346129721.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1780190346129721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["XLV","BK4581","LABU","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://us.spdrs.com/etf/health-care-select-sector-spdr-fund-XLV","stockEarnings":[{"period":"1week","weight":-0.0304},{"period":"1month","weight":0.0141},{"period":"3month","weight":0.028},{"period":"6month","weight":-0.0358},{"period":"1year","weight":0.1213},{"period":"ytd","weight":-0.0349}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"本基金追踪标普健康板块指数(S&P Health Care Select Sector index)，并将95%以上的资产投资在该指数包含的成分股，其中包含了医疗保健、生物科技、制药相关的公司。\n风险提示：标的成分和权重，有可能随着时间的迁移而发生变化。","yearOnYearQuotes":[{"month":1,"riseRate":0.607143,"avgChangeRate":0.009527},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.002019},{"month":3,"riseRate":0.571429,"avgChangeRate":0.0058},{"month":4,"riseRate":0.535714,"avgChangeRate":0.012982},{"month":5,"riseRate":0.678571,"avgChangeRate":0.005168},{"month":6,"riseRate":0.5,"avgChangeRate":0.002687},{"month":7,"riseRate":0.62963,"avgChangeRate":0.011509},{"month":8,"riseRate":0.555556,"avgChangeRate":0.001611},{"month":9,"riseRate":0.37037,"avgChangeRate":-0.015959},{"month":10,"riseRate":0.592593,"avgChangeRate":0.007405},{"month":11,"riseRate":0.777778,"avgChangeRate":0.02456},{"month":12,"riseRate":0.666667,"avgChangeRate":0.010581}],"exchange":"ARCA","name":"健康照护类股ETF-SPDR","nameEN":"Health Care Select Sector SPDR Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健康照护类股ETF-SPDR(XLV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健康照护类股ETF-SPDR,XLV,健康照护类股ETF-SPDR股票,健康照护类股ETF-SPDR股票老虎,健康照护类股ETF-SPDR股票老虎国际,健康照护类股ETF-SPDR行情,健康照护类股ETF-SPDR股票行情,健康照护类股ETF-SPDR股价,健康照护类股ETF-SPDR股市,健康照护类股ETF-SPDR股票价格,健康照护类股ETF-SPDR股票交易,健康照护类股ETF-SPDR股票购买,健康照护类股ETF-SPDR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健康照护类股ETF-SPDR(XLV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}